Every physician can recall the diagnoses they were taught never to miss. The lessons begin early in training and repeat themselves throughout residency, reinforced by attendings, board examinations, and the unforgettable patients whose stories become cautionary tales. Chest pain may be indigestion until it proves to be an aortic dissection. A headache may be stress until it becomes a subarachnoid hemorrhage. Back pain may be muscular until it reveals spinal cord compression. Medical education is built around vigilance, and for good reason. The consequences of overlooking a dangerous diagnosis can be devastating. From the first days of training, physicians learn that the greatest mistake is often the disease that went undiscovered.
That philosophy has shaped generations of clinicians. Medicine has become extraordinarily good at finding what once remained hidden. Imaging has evolved from plain radiographs to sophisticated CT scans, MRI, PET imaging, ultrasound, and increasingly detailed three-dimensional visualization. Laboratory testing has become more sensitive. Genetic testing can identify inherited risks decades before illness develops. Wearable devices continuously monitor heart rhythms and physiologic changes that would have gone unnoticed only a generation ago. Artificial intelligence promises to recognize patterns invisible to even the most experienced clinicians. Every advance moves medicine closer to its longstanding ambition: discovering disease earlier, before symptoms appear and before opportunities for intervention are lost.
AI is moving fast. Our course helps healthcare professionals keep up, with expert-led conversations on advocacy, automation, women leading in AI, ethics, regulation, and the questions medicine can’t afford to ignore.
For most of modern medical history, that trajectory has seemed unquestionably desirable. Few public health messages have been more persuasive than “early detection saves lives.” Screening programs for cervical cancer, colon cancer, breast cancer, and abdominal aortic aneurysms have prevented countless deaths. Physicians have celebrated earlier diagnosis because earlier diagnosis often means more treatment options, less invasive interventions, and better outcomes. Entire specialties have been built around the idea that medicine should not wait for disease to announce itself through suffering.
Yet as our ability to detect abnormalities accelerates, an uncomfortable question has begun to emerge. What happens when medicine becomes so effective at finding disease that it begins discovering abnormalities that were never destined to become illness at all?
This question sits at the center of a quiet transformation in healthcare. Increasingly, physicians are not evaluating patients because symptoms have appeared. Instead, they are interpreting findings generated by increasingly sophisticated technologies that searched for disease before patients ever felt unwell. Whole-body imaging identifies small nodules in the lungs, thyroid, kidneys, adrenal glands, liver, and pancreas. Advanced blood tests identify biomarkers whose long-term significance remains uncertain. Genetic analyses reveal mutations associated with elevated risk but unpredictable outcomes. Artificial intelligence may soon detect subtle physiologic changes long before traditional diagnostic methods recognize them.
Join our private community to explore publishing, real estate, wealth-building, creative projects, & everything that keeps us curious, ambitious, and a little more alive.
Some of these discoveries will unquestionably save lives. Others will create uncertainty where none previously existed.
Medicine already has a word for many of these findings: incidentalomas. The name itself reflects the dilemma. An incidentaloma is an abnormality discovered unintentionally while searching for something else. Most physicians have encountered them countless times. A CT scan performed after a minor accident identifies a small adrenal mass. An MRI ordered for back pain reveals a renal cyst. A lung nodule appears on imaging obtained for an unrelated reason. In many cases, these findings prove entirely benign. Yet once they are documented, they become difficult to ignore. They generate repeat imaging, specialist consultations, biopsies, surveillance protocols, additional testing, and, perhaps most significantly, months or years of uncertainty for the patient who now knows something exists inside their body that they had never imagined before. This is where medicine’s remarkable success begins to create one of its newest ethical challenges.
For generations, physicians feared missing disease because missed disease often carried obvious consequences. The patient who returned months later with metastatic cancer or a ruptured aneurysm represented a painful reminder of what had escaped detection. Finding more seemed unquestionably better than finding less. But modern medicine increasingly occupies a different landscape, one in which discovering an abnormality does not necessarily answer a question. Sometimes it creates dozens of new ones.
Menopause deserves more than whispers, hot-flash jokes, and confusing advice from the internet. SoMeDocs is curating a virtual lineup covering psychology, intimacy, symptom support, and clinical insight for the public and healthcare professionals alike.
Patients often assume that more information automatically leads to better decisions. It is an understandable instinct. Information feels empowering. Knowledge feels protective. Yet medicine has long recognized that not every abnormality deserves intervention. Autopsy studies have demonstrated that many people die with small cancers that never affected their lives. Imaging frequently identifies spinal abnormalities in people with no back pain whatsoever. Tiny thyroid cancers, once aggressively treated, are now increasingly managed through active surveillance because many would never have progressed to cause harm. The body is far less anatomically perfect than medical illustrations suggest. Healthy people often contain imperfections.
The challenge, then, is no longer simply identifying abnormalities, but rather determining which abnormalities matter.
Artificial intelligence has the potential to magnify this dilemma. Much of the conversation surrounding AI has focused on accuracy. Can it detect melanoma better than dermatologists? Can it identify breast cancer earlier than radiologists? Can it recognize subtle electrocardiographic changes that physicians overlook? These are important questions, and the technology continues to demonstrate impressive capabilities. But another question receives far less attention. What happens when AI becomes exceptionally good at identifying findings whose clinical significance remains uncertain? A machine capable of detecting ever-smaller abnormalities may not simply diagnose more disease. It may also discover more possibilities, more ambiguities, and more reasons for patients to enter the healthcare system despite feeling entirely well.
Doctor Directory
The internet is crowded. Real expertise should be easier to find. SoMeDocs features forward-thinking healthcare innovators in creative, searchable, and highly visible ways.
This isn’t an argument against innovation. Quite the opposite. The history of medicine is filled with technologies that initially raised concerns before becoming indispensable. Few physicians would willingly return to practicing without CT scanners, colonoscopy, mammography, echocardiography, or advanced laboratory testing. Earlier diagnosis has transformed countless diseases from fatal conditions into treatable ones. It would be difficult to argue that medicine should intentionally become less capable of recognizing illness.
The more interesting question is whether our philosophy of detection has evolved as quickly as our technology. Medicine has traditionally approached diagnosis as though every disease exists in one of two states: present or absent. Increasingly, however, physicians find themselves operating within a spectrum of probability. An abnormality may represent disease today, disease tomorrow, or disease never. A genetic mutation may increase lifetime risk without guaranteeing illness. A biomarker may predict future disease in one patient while remaining clinically irrelevant in another. The certainty physicians once sought through testing has gradually been replaced by increasingly nuanced estimates of possibility.
That shift changes the physician’s role in profound ways. For generations, doctors were trained primarily as diagnosticians, skilled at uncovering hidden illness. Tomorrow’s physicians may spend just as much time helping patients understand findings that do not yet have clear answers. The challenge will be less about locating disease than interpreting risk, balancing uncertainty, and helping patients distinguish between information that improves health and information that merely expands anxiety.
The lecture hall just moved to your couch. Explore on-demand talks from verified healthcare professionals, filter by topic, and learn whenever curiosity strikes.
How to Avoid Obstacles in the Creation of an App
Would You Podcast if it Helped Your Patients? Reasons, Tools, & Action
How and Why Digital Communication Builds Professional Power (and What You Can Do to Get In)
Healing Pelvic Pain
Panel Discussion: CTRL + ALT + REACH: Mastering the Art of Connection on Social Media
Making Friends with Fear in Order to Grow Your Impact
Medical Billing Metrics to Thrive
How to Enhance the Patient Experience & Inspire 5-Star Reviews: Adele Gutman Milne
Handling Derailment: What to Do When Your Career is Disrupted
Patients, too, may need to reconsider what they expect from preventive medicine. It is tempting to believe that every additional test represents another layer of protection. Sometimes it does. Sometimes it simply opens a door that cannot easily be closed. Every unexpected finding carries downstream consequences: additional appointments, repeat imaging, invasive procedures, financial costs, emotional stress, and the psychological burden of wondering whether today’s uncertainty may become tomorrow’s diagnosis.
Perhaps this is the paradox of modern medicine. The profession has spent decades striving to eliminate uncertainty through earlier detection, only to discover that greater sensitivity often reveals entirely new forms of uncertainty. The more deeply we search, the more frequently we encounter abnormalities whose meaning remains unsettled.
None of this suggests that medicine should stop looking. It suggests that the next era of healthcare may require a different kind of wisdom than the last. The great challenge may no longer be discovering what was previously invisible. It may be learning when discovery genuinely serves patients and when it simply enlarges the boundaries of medicine without improving the lives of the people it hopes to protect.
For generations, physicians have been taught that the greatest danger lies in overlooking disease. That lesson remains true. But as artificial intelligence, advanced imaging, genomics, and increasingly sophisticated screening technologies reshape preventive care, medicine may need to embrace a second principle alongside the first. Finding disease early can save lives. Finding everything, however, is not necessarily the same as helping people live better ones.
With "incidentalomas", the name itself reflects the dilemma. An incidentaloma is an abnormality discovered unintentionally while searching for something else.
